Can SGLT-2 inhibitors resolve the heart failure burden of diabetes mellitus - Is it empaglifozin or the class?

被引：0
作者：
Tschoepe, Diethelm [1 ]
机构：
[1] Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia Bad Oey, Diabet Ctr, Bochum, Germany
来源：
JOURNAL OF DIABETES AND ITS COMPLICATIONS | 2017年 / 31卷 / 07期
关键词：
EMPAGLIFLOZIN; MORTALITY; OUTCOMES; TYPE-1;
D O I：
10.1016/j.jdiacomp.2017.04.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1075 / 1076
页数：2
相关论文
共 9 条
  • [1] Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
    Baartscheer, Antonius
    Schumacher, Cees A.
    Wust, Rob C. I.
    Fiolet, Jan W. T.
    Stienen, Ger J. M.
    Coronel, Ruben
    Zuurbier, Coert J.
    [J]. DIABETOLOGIA, 2017, 60 (03) : 568 - 573
  • [2] Association of Cardiometabolic Multimorbidity With Mortality The Emerging Risk Factors Collaboration
    Di Angelantonio, Emanuele
    Kaptoge, Stephen
    Wormser, David
    Willeit, Peter
    Butterworth, Adam S.
    Bansal, Narinder
    O'Keeffe, Linda M.
    Gao, Pei
    Wood, Angela M.
    Burgess, Stephen
    Freitag, Daniel F.
    Pennells, Lisa
    Peters, Sanne A.
    Hart, Carole L.
    Haheim, Lise Lund
    Gillum, Richard F.
    Nordestgaard, Borge G.
    Psaty, Bruce M.
    Yeap, Bu B.
    Knuiman, Matthew W.
    Nietert, Paul J.
    Kauhanen, Jussi
    Salonen, Jukka T.
    Kuller, Lewis H.
    Simons, Leon A.
    van der Schouw, Yvonne T.
    Barrett-Connor, Elizabeth
    Selmer, Randi
    Crespo, Carlos J.
    Rodriguez, Beatriz
    Verschuren, W. M. Monique
    Salomaa, Veikko
    Svardsudd, Kurt
    van der Harst, Pim
    Bjorkelund, Cecilia
    Wilhelmsen, Lars
    Wallace, Robert B.
    Brenner, Hermann
    Amouyel, Philippe
    Barr, Elizabeth L. M.
    Iso, Hiroyasu
    Onat, Altan
    Trevisan, Maurizio
    D'Agostino, Ralph B., Sr.
    Cooper, Cyrus
    Kavousi, Maryam
    Welin, Lennart
    Roussel, Ronan
    Hu, Frank B.
    Sato, Shinichi
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (01): : 52 - 60
  • [3] Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial
    Fitchett, David
    Zinman, Bernard
    Wanner, Christoph
    Lachin, John M.
    Hantel, Stefan
    Salsali, Afshin
    Johansen, Odd Erik
    Woerle, Hans J.
    Broedl, Uli C.
    Inzucchi, Silvio E.
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    Lienart, F.
    Mortelmans, J.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (19) : 1526 - 1534
  • [4] Changes in Diabetes-Related Complications in the United States, 1990-2010
    Gregg, Edward W.
    Li, Yanfeng
    Wang, Jing
    Burrows, Nilka Rios
    Ali, Mohammed K.
    Rolka, Deborah
    Williams, Desmond E.
    Geiss, Linda
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (16) : 1514 - 1523
  • [5] SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
    Inzucchi, Silvio E.
    Zinman, Bernard
    Wanner, Christoph
    Ferrari, Roberto
    Fitchett, David
    Hantel, Stefan
    Espadero, Rosa-Maria
    Woerle, Hans-Juergen
    Broedl, Uli C.
    Johansen, Odd Erik
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (02) : 90 - 100
  • [6] Kosiborod M, 2017, 66 SCI SESS AM COLL
  • [7] Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial
    Kristensen, Soren L.
    Preiss, David
    Jhund, Pardeep S.
    Squire, Iain
    Cardoso, Jose Silva
    Merkely, Bela
    Martinez, Felipe
    Starling, Randall C.
    Desai, Akshay S.
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Rouleau, Jean L.
    Shi, Victor C.
    Solomon, Scott D.
    Swedberg, Karl
    Zile, Michael R.
    McMurray, John J. V.
    Packer, Milton
    [J]. CIRCULATION-HEART FAILURE, 2016, 9 (01)
  • [8] Range of Risk Factor Levels Control, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus
    Rawshani, Aidin
    Rawshani, Araz
    Franzen, Stefan
    Eliasson, Bjorn
    Svensson, Ann-Marie
    Miftaraj, Mervete
    McGuire, Darren K.
    Sattar, Naveed
    Rosengren, Annika
    Gudbjornsdottir, Soffia
    [J]. CIRCULATION, 2017, 135 (16) : 1522 - +
  • [9] Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
    Rawshani, Aidin
    Rawshani, Araz
    Franzen, Stefan
    Eliasson, Bjorn
    Svensson, Ann-Marie
    Miftaraj, Mervete
    McGuire, Darren K.
    Sattar, Naveed
    Rosengren, Annika
    Gudbjornsdottir, Soffia
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (15) : 1407 - 1418
1